ACETO Corp (ACET) Reports Q4 Loss of $0.48/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
- Nebius shares sink on CoreWeave's bond yield spike and insider sales
- IonQ prices $2 billion equity offering at $40 per share
- Rocket Lab delays Neutron rocket debut to 2027
- Bloom Energy stock falls as inflation data pressures markets
- Nasdaq ends sharply lower as hot inflation data stirs rate-hike worries
ACETO Reports Fiscal 2018 Fourth Quarter and Full-Year Results
September 28, 2018 6:59 AM EDTPerformance Chemicals and Pharmaceutical Ingredients Continue Strong Performance
Repaid $43.2 Million of Debt During Fiscal Year 2018
PORT WASHINGTON, N.Y., Sept. 28, 2018 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ: ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today financial results for the fiscal 2018 fourth quarter and fiscal year ended June 30, 2018.
Fourth Quarter Fiscal 2018 versus Fourth Quarter Fiscal 2017
Net sales of $168.9 million versus $194.6... More


